西曲酸酯(cetraxte,氨己烷酸苯酯)是一种细胞保护药物。业已证明,本药治疗消化性溃疡有效。作者评估了西曲酸酯与西咪替丁对比治疗消化性溃疡的疗效。 44例患者,于内窥镜检查后5天内随机接受西曲酸酯400mg,b.i.d.或西咪替丁400mg,b.i.d治疗,连续6周。第2周和第6周结束时作临床评价。42例完成了此试验,其中西咪替丁20例(十二指肠溃疡14例和胃溃疡6例),西曲酸酯22例(十二指肠溃疡18例和 Cetraxte (phenylhexanoate) is a cytoprotective drug. It has been proven that the drug is effective in treating peptic ulcer. The authors evaluated the efficacy of cimetidine versus cimetidine in the treatment of peptic ulcer disease. Forty-four patients were randomized to receive either Alcalase 400 mg, b.i.d., or cimetidine 400 mg, b.i.d for 5 weeks after endoscopy for 6 weeks. Weeks 2 and 6 at the end of the clinical evaluation. Forty-two patients completed the trial, with 20 cases of cimetidine (14 cases of duodenal ulcer and 6 cases of gastric ulcer), 22 cases of cerulopalatine (18 cases of duodenal ulcer and